BAN2401 Shows Promise in Treating Early Alzheimer Disease

06:25 EDT 15 Sep 2018 | Neurology Times

A new drug called BAN2401 has shown promise in decreasing amyloid in early AD, according to results from a phase II study.

Original Article: BAN2401 Shows Promise in Treating Early Alzheimer Disease


More From BioPortfolio on "BAN2401 Shows Promise in Treating Early Alzheimer Disease"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...